Dr.NISHA BURA

Dr. CHAWLA URMIL, Dr. ASHOK KUMAR KHURANA, Dr.Richa Sharma

Abstract

This study was conducted to study the effect of using a low dose of Mitomycin-C (0.2 mg/ml) as an adjunct for probing to treat adults with primary acquired nasolacrimal duct (NLD) obstruction .This was a prospective, comparative, randomised interventional study. Cases (20 eyes) of primary acquired NLD obstruction were treated with probing and intraoperative Mitomycin-C (MMC) and Controls (20 eyes) with primary acquired NLD obstruction were treated with only probing. At the end of 4 months, subjective improvement in epiphora and patency on syringing were evaluated. Our study confirmed the efficacy of probing with MMC in reducing the symptoms of epiphora in patients with NLD obstruction during 4 months of follow-up which will be discussed later.